• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Niowave Expands Lansing, Michigan, Operations

Niowave, Inc., a global producer of medical isotopes, plans to expand its operations complex in Lansing, Michigan. The $20 million project is expected to create 35 jobs.

Located near the Capital Region International Airport the company will increase production of several medical radioisotopes used in diagnostic and therapeutic treatments. Niowave currently ships cancer treatments from its Lansing facilities.

“Niowave chose mid-Michigan as home nearly 20 years ago because of the unique combination of science and advanced manufacturing talent,” said Niowave President Mike Zamiara. “We made the right decision then and are excited to expand here now.”

The project is being supported by a $500,000 Jobs Ready Michigan Program performance-based grant and falls within the Next Michigan Development Corporation, an intergovernmental agreement between the city of Lansing and DeWitt Township, with participation from Capital Region Airport Authority.

“Niowave’s continued growth in mid-Michigan underscores our state’s leadership in high tech and life sciences, as well as the strength of our business climate and talented workforce,” noted?MEDC Senior Vice President of Regional Prosperity Matt McCauley. “This project is a win for Lansing and for the entire state. We are grateful to Governor Whitmer, legislators from both parties, and local officials for their continued support for our programs that help make announcements like today’s possible. We appreciate the efforts of our local partners in supporting this project and look forward to partnering with Niowave as it continues to grow and add jobs for Michigan residents.”

The company is working with local officials and the Lansing Economic Area Partnership (LEAP) to identify possible support for the project, and Next Michigan Development Corporation is considering a PA-198 Industrial Facilities Tax Abatement.

“Niowave is one of the great economic development stories of our region and country,” added Bob Trezise, president and CEO of LEAP. “Locally grown and now of international import, expanding again through the hard teamwork of so many local and state partners especially the MEDC, Clinton County, city of Lansing, Dewitt Township, the airport and of course our staff here at LEAP. We continue to believe that the Lansing region is the Particle Accelerator Capital of North America.”

Niowave supplies medical and industrial radioisotopes produced from uranium and radium. The company is a global leader in research, development, manufacturing and operation of superconducting electron linear accelerators which are used for medical radioisotope production. Niowave was established in 2005 as a spinoff from the National Superconducting Cyclotron Lab, the laboratory now known as Facility for Rare Isotope Beams (FRIB).

Exclusive Research